Genetic testing for familial hypercholesterolemia

Session:
#235
Date:
Thursday, Apr 26, 2018 8:00am – 5:30pm
Conference:
Authors:
Andy Castro, Christian Antolik, Jessica Gage, Jill Dolinsky, Lily Hoang, Tami Johnston
  • Comprehensive genetic analysis of patients at risk for FH identified causative mutations in 37% of cases.
  • While cholesterol levels were higher overall for positive cases, the range was relatively large, and one individual screened at age 36 had an LDL of 173 mg/uL, below the professionally recommended threshold for suspected FH (>190 mg/dL for individuals over 20).
  • Patients heterozygous for APOB mutations had near-significantly lower mean LDL levels than LDLR heterozygotes (p=0.052), supporting similar reports of milder presentations with APOB mutations.